Discontinuation rate of sulfasalazine, leflunomide and methotrexate due to adverse events in a real-life setting (NOR-DMARD)

OBJECTIVES: MTX, LEF and SSZ are conventional synthetic DMARDs (csDMARDs) with a well-established role in the treatment of RA. We aimed to estimate and compare the relative risks for adverse events (AEs) and the discontinuation of these drugs owing to AEs. METHODS: We included all 3339 patients from...

Descripción completa

Detalles Bibliográficos
Autores principales: Mielnik, Pawel, Sexton, Joseph, Fagerli, Karen M, Bakland, Gunnstein, Hu, Yi, Kristianslund, Eirik K, Hoff, Mari, Wierød, Ada, Kvien, Tore K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Concise Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329773/
https://www.ncbi.nlm.nih.gov/pubmed/37431434
http://dx.doi.org/10.1093/rap/rkad053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329773/
https://www.ncbi.nlm.nih.gov/pubmed/37431434
http://dx.doi.org/10.1093/rap/rkad053

Ejemplares similares